Italia markets close in 7 hours 9 minutes

WVE Oct 2024 7.500 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,3500-0,4500 (-56,25%)
In data: 11:14AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,8000
Aperto0,3000
Denaro0,3000
Domanda0,6000
Prezzo d'esercizio7,50
Scadenza2024-10-18
Min-Max giorno0,3000 - 0,3500
Contratto - Min-MaxN/D
Volume14
Open Interest441
  • GlobeNewswire

    Wave Life Sciences Highlights Growth Strategy for Building the Leading RNA Medicines Company in Annual R&D Day

    Presented preclinical proof-of-concept data for new, wholly owned program targeting INHBE for metabolic disorders, including obesity, which uses Wave’s best-in-class GalNAc-siRNA capabilities and novel genetic insights from GSK WVE-006 – industry’s first-ever RNA editing clinical candidate – on track for dosing in RestorAATion clinical trial in 4Q 2023 and first human proof-of-mechanism data in 2024 Advancing multiple, wholly owned RNA editing targets using correction and upregulation approaches

  • GlobeNewswire

    Wave Life Sciences to Present at the Chardan 7th Annual Genetic Medicines Conference

    CAMBRIDGE, Mass., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to present at the Chardan 7th Annual Genetic Medicines Conference in New York City on Monday, October 2, 2023. Dr. Bolno will participate in the ADAR Editing Panel at 9:30 a.m. ET and

  • GlobeNewswire

    Wave Life Sciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference

    CAMBRIDGE, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to participate in a virtual analyst-led fireside chat at the H.C. Wainwright 25th Annual Global Investment Conference. The presentation will be available to view beginning on Monday, S